# Prostate Metabolism, Cancer Risk and Gut Microbiota

> **NCT06116851** · — · RECRUITING · sponsor: **Turku University Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Prostate Cancer
- Prostate Hyperplasia

## Interventions

- **OTHER:** MRI scan and laboratory visit
- **PROCEDURE:** Prostate biopsies
- **PROCEDURE:** Radical prostatectomy and blood, urine and tissue sampling
- **PROCEDURE:** TURP and blood, urine and tissue sampling
- **PROCEDURE:** Radical cystoprostatectomy and blood, urine and tissue sampling

## Key facts

- **NCT ID:** NCT06116851
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-01
- **Primary completion:** 2024-01-15
- **Final completion:** 2026-09-15
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-11-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06116851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06116851, "Prostate Metabolism, Cancer Risk and Gut Microbiota". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06116851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*